Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arminder K Deol

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
PLOS Global Public Health|March 24, 2023
Direct estimates of absolute ventilation and estimated Mycobacterium tuberculosis transmission risk in clinics in South AfricaPeter G Beckwith, Aaron S Karat, Indira Govender, et al.
Parasites & Vectors|April 30, 2017
Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluationsHugo C Turner, James E Truscott, Alison A Bettis, et al.
Plos One|June 24, 2021
Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogensArminder K Deol, Danny Scarponi, Peter Beckwith, et al.
Plos Neglected Tropical Diseases|May 25, 2021
Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoniRyan E Wiegand, W Evan Secor, Fiona M Fleming, et al.
BMJ Global Health|October 26, 2021
Modelling the effect of infection prevention and control measures on rate of <i>Mycobacterium tuberculosis</i> transmission to clinic attendees in primary health clinics in South AfricaNicky McCreesh, Aaron S Karat, Kathy Baisley, et al.
The New England Journal of Medicine|December 28, 2019
Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global GoalsArminder K Deol, Fiona M Fleming, Beatriz Calvo-Urbano, et al.
Plos Medicine|January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyAllison Portnoy, Rebecca A Clark, Matthew Quaife, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
PLOS Global Public Health|March 24, 2023
Direct estimates of absolute ventilation and estimated Mycobacterium tuberculosis transmission risk in clinics in South AfricaPeter G Beckwith, Aaron S Karat, Indira Govender, et al.
Parasites & Vectors|April 30, 2017
Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluationsHugo C Turner, James E Truscott, Alison A Bettis, et al.
Plos One|June 24, 2021
Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogensArminder K Deol, Danny Scarponi, Peter Beckwith, et al.
Plos Neglected Tropical Diseases|May 25, 2021
Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoniRyan E Wiegand, W Evan Secor, Fiona M Fleming, et al.
BMJ Global Health|October 26, 2021
Modelling the effect of infection prevention and control measures on rate of <i>Mycobacterium tuberculosis</i> transmission to clinic attendees in primary health clinics in South AfricaNicky McCreesh, Aaron S Karat, Kathy Baisley, et al.
The New England Journal of Medicine|December 28, 2019
Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global GoalsArminder K Deol, Fiona M Fleming, Beatriz Calvo-Urbano, et al.
Plos Medicine|January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyAllison Portnoy, Rebecca A Clark, Matthew Quaife, et al.
Pageof 1